Continuing the Global Debate: The Latest Developments in Climate Change and Greenhouse-Gas Initiatives
March 18, 2010
Foley’s Environmental Regulation attorneys presented Continuing the Global Debate: The Latest Developments in Climate Change and Greenhouse-Gas Initiatives. Foley attorneys provided an overview and analysis of climate change dialogue and activities currently taking place in Congress, U.S. EPA, and at the state and regional levels.
Topics included:
- The latest proposals in Congress to suspend EPA’s Clean Air Act (CAA) authority to regulate GHGs from stationary sources for two years, while allowing EPA to move forward with its plans for motor vehicle GHG controls — or to prohibit EPA from moving forward with any CAA GHG regulations
- Recent announcements by EPA Administrator Lisa Jackson that EPA will greatly cut back on the scope and timing of its upcoming “tailoring” program for stationary sources — such as increasing the proposed 25,000 tons per year (TPY) limit to 75,000 or 100,000
- The status of D.C. Circuit judicial review over EPA’s CAA GHG rules and the “Endangerment Finding”
- The GHG highlights in EPA’s final CAA “Renewable Fuels Standards” that will soon be published in the Federal Register
- The status of activities in the states, regionally and individually, to respond to climate change through GHG-emission reduction initiatives and the development of climate mitigation and adaptation plans
About the Environmental Law Update Web Conference Series
The Environmental Law Update Web Conference Series provides participants with needed information in the most efficient manner possible — only a telephone line and Internet access are required to participate. Environmental leaders can stay up-to-date with timely information from anywhere in the nation.
People
Related Insights
April 15, 2026
Foley Viewpoints
Key Health Care Enforcement Trends Under the Trump Administration: FCA, Data Analytics, and Emerging Risk Areas
These trends included (i) an enduring focus on waste, fraud, and abuse in the health care industry; (ii) a continued focus on Medicare Advantage and a newer focus on gender transition procedures for minors; and (iii) the ever-increasing use of data analytics to prosecute cases.
April 14, 2026
Health Care Law Today
FDA Clarifies Policies for Pharmacy Compounders of GLP-1 Products
On April 1, 2026,the U.S. Food & Drug Administration (FDA) issued a statement clarifying its compliance policy on the conditions that must be met for compounded drugs to qualify for the exemptions under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
April 14, 2026
Foley Career Perspectives
Trust Your Instincts: Susan Pravda on Leadership, Relationships, and Resilience
Foley partner Susan Pravda is a business lawyer focused on mergers and acquisitions, venture capital, initial public offerings, and related securities transactions and is head of Foley’s Health Care & Life Sciences Sector. She also serves as the firm’s chief strategic talent acquisition partner.